Literature DB >> 7225969

Recurrent hiatal hernia: management by thoracoabdominal total fundoplication gastroplasty.

R D Henderson, G Marryatt.   

Abstract

Recurrent hiatal hernia presents a difficult diagnostic and therapeutic challenge. The authors present a series of 121 patients in whom recurrent hiatal hernia was investigated by history, radiology, endoscopy and manometry and acid perfusion testing before surgical correction by thoracoabdominal total fundoplication gastroplasty. The preoperative findings were compared with those of 238 patients who had undergone primary repair. Roentgenography was found to be less accurate in the diagnosis of anatomic recurrence than of the original hernia. Manometry and endoscopy increased the diagnostic accuracy of recurrent hernia. The thoracoabdominal approach was used to allow direct vision dissection both above and below the diaphragm. Gastroplasty minimized the risk of anatomic recurrence and allowed reflux control even in patients with an irreducible hiatal hernia. Total fundoplication, added to gastroplasty, is the most effective method of preventing reflux. There were no anatomic recurrences and no evidence of reflux in the 121 patients who had secondary repair. Two patients have required further surgery to modify the total fundoplication gastroplasty. With a 96.7% follow-up, 94.2% of the patients are considered to have excellent results.

Entities:  

Mesh:

Year:  1981        PMID: 7225969

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  2 in total

1.  Correlations between esophageal diseases and manometric length: a study of 617 patients.

Authors:  Z T Awad; P Watson; C J Filipi; R E Marsh; T Tomonaga; Y Shiino; S Bhatia; W Boedefeld
Journal:  J Gastrointest Surg       Date:  1999 Sep-Oct       Impact factor: 3.452

Review 2.  Surgical reintervention after failed antireflux surgery: a systematic review of the literature.

Authors:  Edgar J B Furnée; Werner A Draaisma; Ivo A M J Broeders; Hein G Gooszen
Journal:  J Gastrointest Surg       Date:  2009-04-04       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.